Health or Wealth? The Cost of Big Pharma’s Influence on U.S. Healthcare Policy
Year after year, the pharmaceutical industry ranks among the top spenders in lobbying efforts in Washington, D.C., pouring hundreds of millions into influencing drug approval processes and pricing. This financial influence secures patents and market exclusivity for new drugs, creating monopolies that keep prices high and limit affordable alternatives. Platforms like Ashvin Medicara offer transparency and education about cost-effective pharmaceuticals. It’s crucial for the public to demand open dialogues and reforms to prioritize accessible and affordable healthcare for all.